Key result
Percutaneous coronary intervention reduced the risk of cardiac death compared to medication alone in hemodialysis patients with coronary artery disease (OR 0.14; 95% CI 0.08-0.25; P=0.0006).
Why the study?
Does percutaneous coronary intervention reduce cardiac death compared to medical therapy in hemodialysis patients with coronary artery disease?
Cohort (n=259)
Does percutaneous coronary intervention reduce cardiac death compared to medical therapy in hemodialysis patients with coronary artery disease?
Odds Ratio: 0.14 (95% CI 0.08–0.25)
Absolute Event Rate: 77.1% vs 41.6%
p-value: p=0.0006
In hemodialysis patients with coronary artery disease, percutaneous coronary intervention significantly improves both cardiac and all-cause survival compared to medical therapy alone.
Authors
No takes yet. Share an insight, caveat, or question.
May support PCI consideration in hemodialysis patients with CAD; leaves open need for RCTs to confirm benefit.
Yasuda et al. (2006) conducted a cohort in Coronary artery disease in hemodialysis patients (n=259). Percutaneous coronary intervention vs. Medication only was evaluated on Cardiac death (OR 0.14, 95% CI 0.08-0.25, p=0.0006). Percutaneous coronary intervention reduced the risk of cardiac death compared to medication alone in hemodialysis patients with coronary artery disease (OR 0.14; 95% CI 0.08-0.25; P=0.0006).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: